1 OMEPRAZOLE | 120 of 1650 | 4760 prescriptions Less than 1% of all prescriptions | 4130 | 1180 patients 14% of all patients | 1050 patients 13% of all patients | |
2 PANTOPRAZOLE SODIUM | 460 of 1720 | 3820 prescriptions Less than 1% of all prescriptions | 3200 | 910 patients 11% of all patients | 770 patients 9% of all patients | |
3 SUCRALFATE | 150 of 1010 | 950 prescriptions Less than 1% of all prescriptions | 790 | 410 patients 5% of all patients | < 11 | |
4 COLESTIPOL HCL | 70 of 500 | 940 prescriptions Less than 1% of all prescriptions | 780 | 300 patients 4% of all patients | < 11 | |
5 ESOMEPRAZOLE MAGNESIUM | 300 of 1230 | 580 prescriptions Less than 1% of all prescriptions | 450 | 110 patients 1% of all patients | < 11 | |
6 DEXILANT (DEXLANSOPRAZOLE) | 230 of 870 | 650 prescriptions Less than 1% of all prescriptions | 530 | < 11 | < 11 | |
7 BUDESONIDE EC (BUDESONIDE) | 10 of 510 | 630 prescriptions Less than 1% of all prescriptions | | 190 patients 2% of all patients | < 11 | |
8 METOCLOPRAMIDE HCL | 90 of 500 | 520 prescriptions Less than 1% of all prescriptions | 220 | 210 patients 3% of all patients | < 11 | |
9 LINZESS (LINACLOTIDE) | 470 of 1240 | 390 prescriptions Less than 1% of all prescriptions | 230 | < 11 | < 11 | |
10 HUMIRA PEN (ADALIMUMAB) | 60 of 500 | 430 prescriptions Less than 1% of all prescriptions | 280 | < 11 | < 11 | |
11 DICYCLOMINE HCL | 450 of 1270 | 510 prescriptions Less than 1% of all prescriptions | 270 | 170 patients 2% of all patients | < 11 | |
12 AZATHIOPRINE | 200 of 670 | 220 prescriptions Less than 1% of all prescriptions | | < 11 | < 11 | |
13 APRISO (MESALAMINE) | 190 of 650 | 240 prescriptions Less than 1% of all prescriptions | | < 11 | < 11 | |
14 LANSOPRAZOLE | 160 of 480 | 240 prescriptions Less than 1% of all prescriptions | | < 11 | < 11 | |
15 WELCHOL (COLESEVELAM HCL) | 110 of 290 | 200 prescriptions Less than 1% of all prescriptions | 200 | < 11 | < 11 | |
16 METRONIDAZOLE | 20 of 650 | 550 prescriptions Less than 1% of all prescriptions | | 440 patients 5% of all patients | < 11 | A |
17 CREON (LIPASE/PROTEASE/AMYLASE) | 240 of 500 | 120 prescriptions Less than 1% of all prescriptions | 120 | < 11 | < 11 | |
18 GAVILYTE-G (PEG3350/SOD SULF,BICARB,CL/KCL) | 10 of 660 | 3480 prescriptions Less than 1% of all prescriptions | 2970 | 3380 patients 41% of all patients | 2880 patients 35% of all patients | |
19 ONDANSETRON ODT (ONDANSETRON) | 210 of 770 | 250 prescriptions Less than 1% of all prescriptions | | < 11 | < 11 | |
20 PREDNISONE | 170 of 360 | 170 prescriptions Less than 1% of all prescriptions | | < 11 | < 11 | |
21 OMEPRAZOLE-SODIUM BICARBONATE (OMEPRAZOLE/SODIUM BICARBONATE) | 40 of 40 | 130 prescriptions Less than 1% of all prescriptions | 130 | < 11 | < 11 | |
22 DIPHENOXYLATE-ATROPINE (DIPHENOXYLATE HCL/ATROPINE) | 260 of 620 | 230 prescriptions Less than 1% of all prescriptions | 230 | < 11 | < 11 | |
23 SPIRONOLACTONE | 260 of 460 | 110 prescriptions Less than 1% of all prescriptions | 110 | < 11 | < 11 | |
24 AMOXICILLIN | 110 of 320 | 120 prescriptions Less than 1% of all prescriptions | | 120 patients 1% of all patients | < 11 | A |
25 CLARITHROMYCIN | 110 of 260 | 110 prescriptions Less than 1% of all prescriptions | | 110 patients 1% of all patients | < 11 | A |
26 CIPROFLOXACIN HCL | 140 of 400 | 150 prescriptions Less than 1% of all prescriptions | 150 | 120 patients 1% of all patients | 120 patients 1% of all patients | A |
27 PEG-3350 AND ELECTROLYTES (PEG3350/SOD SULF,BICARB,CL/KCL) | 50 of 250 | 420 prescriptions Less than 1% of all prescriptions | | 400 patients 5% of all patients | < 11 | |
28 PEG 3350-ELECTROLYTE (PEG3350/SOD SULF,BICARB,CL/KCL) | 210 of 330 | 260 prescriptions Less than 1% of all prescriptions | | 260 patients 3% of all patients | < 11 | |
29 SUPREP (SODIUM, POTASSIUM,MAG SULFATES) | 740 of 1200 | 380 prescriptions Less than 1% of all prescriptions | | 380 patients 5% of all patients | < 11 | |
30 MOVIPREP (PEG3350/SOD SUL/NACL/KCL/ASB/C) | 50 of 90 | 150 prescriptions Less than 1% of all prescriptions | | 150 patients 2% of all patients | < 11 | |